The involvement of superoxide-generating NADPH oxidase (NOX) in the cytotoxic effects of cigarette smoke extracts has been documented. However, the underlying molecular mechanisms and NOX isoform involved have not been fully clarified. Among the different NADPH oxidase isoforms identified so far, NOX1 and NOX4 were found to be expressed in rat H9c2 cardiomyocytes. When H9c2 cells were exposed to acrolein or methyl vinyl ketone (MVK), major toxic components of cigarette smoke extracts, a dosedependent decline in cell viability was observed. Unexpectedly, disruption of Nox1 as well as Nox4 significantly exacerbated cytotoxicity induced by acrolein or MVK. Compared with Nox4-disrupted cells, Nox1-disrupted cells were more vulnerable to acrolein and MVK at lower concentrations. Disruption of Nox1 markedly attenuated the levels of total and reduced glutathione (GSH) in H9c2 clones. Reduction in the cystine level in the culture medium to deplete intracellular GSH significantly exacerbated acrolein or MVKinduced cytotoxicity. Nox1 disruption neither attenuated the level of glutamate-cystine antiporter protein nor the activity of glutamate-cysteine ligase, both rate-limiting factors for GSH synthesis. On the other hand, increased expression of multidrug resistance-associated protein 1 (MRP1), which mediates glutathione efflux, was demonstrated in Nox1-disrupted cells. The augmented toxicity of acrolein and MVK in these cells was partially but significantly blunted in the presence of an MRP1 inhibitor, reversan. Taken together, these results show that NOX1/NADPH oxidase regulates the expression of MRP1 to maintain intracellular GSH levels in cardiomyocytes and protect against cytotoxic components of cigarette smoke extracts. A novel crosstalk between NOX1 and MRP1 was demonstrated in this study.
Introduction
Cigarette smoking affects the health of smokers and causes various disorders including cancer and pulmonary and cardiovascular diseases. Evidence linking cigarette smoke exposure to cardiovascular disease (CVD) has been clearly demonstrated. In Asia, more than 30% of smoking-related deaths were attributed to CVD [1] . Among the numerous substances contained in cigarette smoke, the reactive aldehyde acrolein and methyl vinyl ketone (MVK) were recently identified as stable cytotoxic factors that cause membrane damage, reducing cell viability [2] .
Oxidative stress has been suggested to be involved in the pathological process leading to smoking-induced CVD. Smoking generates reactive oxygen species (ROS) that reduce the bioactivity of nitric oxide and initiate inflammatory responses [3] . Among various sources of endogenously generated ROS, NADPH oxidase has been suggested as a major source of ROS induced by smoking [4, 5] . NADPH oxidase is a superoxide-generating enzyme composed of two membranebound subunits and several cytosolic regulatory subunits. There are five homologs of the membranebound catalytic subunit, among which NOX1 is known to play pleiotropic roles in the cardiovascular system [6] . We previously demonstrated that angiotensin IIinduced hypertension was significantly suppressed in mice deficient in Nox1 by maintaining the bioactivity of nitric oxide in the vessel [7] . On the other hand, NOX1 maintains the homeostasis of pulmonary vessels by regulating the turnover of smooth muscle cells [8] . While NOX1 accelerated cardiomyocyte apoptosis in a murine model of sepsis [9] and promoted cardiac fibrosis following doxorubicin-induced cellular damage [10] , a protective role of NOX1 was noted in hypoxia-induced bradycardia in the late phase of ischemic preconditioning [11, 12] . Accordingly, the pathophysiological role of NOX1 in cardiac tissue still remains elusive.
Because acrolein and MVK were reported to cause cellular damage via NADPH oxidase [2] , we examined the potential involvement of the NOX1 isoform of NADPH oxidase in cigarette smoke-induced cardiotoxicity. By regulating the expression of multidrug resistance-associated protein 1 (MRP1), a novel role of NOX1 in cellular glutathione homeostasis was demonstrated in H9c2 cardiomyocytes.
Results

Expression of NOX isoforms in rat myoblast H9c2 cells
To clarify NOX isoform(s) involved in cigarette smoke-induced cardiotoxicity, we first examined gene expression of the isoforms in the murine heart [9] . As shown in Fig. 1A , expression of NOX1 and NOX4, but not of NOX2, was demonstrated in H9c2 cells by RT-PCR. Quantitative PCR (qPCR) revealed that the level of NOX1 mRNA was much lower than that of NOX4, with 3.48 9 10 2 and 3.61 9 10 6 copiesÁlg À1 total RNA, respectively (Fig. 1B) . When cells were exposed to major toxic components of cigarette smoke extracts for 24 h, a significant upregulation of NOX1 was demonstrated by acrolein. On the other hand, NOX4 was significantly upregulated by both acrolein and MVK (Fig. 1D) .
Disruption of Nox1 and Nox4 exacerbated acrolein or MVK-induced cytotoxicity
As shown in Fig. 2A , acrolein and MVK dose-dependently reduced the viability of H9c2 cells. To clarify which NOX isoform(s) is involved in acrolein-or MVK-induced cytotoxicity, we generated Noxdisrupted H9c2 cells by CRISPR-Cas9-mediated genome editing [10] . Because the expression of NOX2 was marginal in these cells, Nox2 disruption did not affect acrolein-or MVK-induced cytotoxicity (Fig. 2B) Table 2) . These results suggest the importance of NOX1/NADPH oxidase in protection against cigarette smoke extract-induced cytotoxicity.
Levels of intracellular glutathione were significantly decreased in Nox1-disrupted cells Glutathione adduct formation is known as a major cellular defense mechanism against acrolein and MVK [13, 14] . When we examined the levels of total and reduced glutathione (GSH), they were significantly decreased in Nox1-disrupted clones (Fig. 3A,B) . On the other hand, the ratio of GSH to oxidized glutathione (GSSG), a marker of oxidative stress, was mostly unchanged among mock-transfected cells and Nox1-disrupted clones (Fig. 3C ). These results suggest that decreased levels of GSH in Nox1-disrupted cells may be due to alteration in GSH metabolism rather than changes in the intracellular redox state.
To verify whether the levels of intracellular GSH play a critical role in the protective effects against acrolein and MVK, H9c2 cells were cultured in medium containing a reduced concentration of L-cystine, a precursor of GSH. As demonstrated in Fig. 4 , increased susceptibility to acrolein and MVK was demonstrated in cells cultured in the medium containing one-third of the cystine concentration.
Expression of MRP1 mRNA was significantly increased in Nox1-disrupted cells
The level of intracellular GSH is regulated by the uptake of L-cystine mediated by a cystine/glutamate exchanger (xCT) and glutamate cysteine ligase (GCL), a rate-limiting enzyme of GSH synthesis. Disruption of Nox1, however, attenuated neither the level of xCT protein, nor the activity of GCL (Fig. 5A,B) . On the other hand, increased expression of MRP1, which mediates the ATP-dependent efflux of GSH and its adducts, was demonstrated in Nox1-disrupted clones (Fig. 5C ). Expression of MRP2, also known as a GSH transporter, was not detected by RT-PCR in H9c2 cells (data not shown). With the use of commercially available antibodies, we could not evaluate the levels of MRP1 protein in these cells.
Reversan, a specific inhibitor of MRP1, restored cell viability affected by acrolein or MVK in Nox1-disrupted cells
To verify whether MRP1 plays a key role in the augmented cytotoxicity of acrolein and MVK in Nox1-disrupted cells, the effects of reversan, an inhibitor of MRP1, were investigated. As shown in Fig. 6A , 20 lM acrolein significantly decreased the viability of mocktransfected cells and Nox1-disrupted clones. In contrast, pretreatment with 10 lM reversan significantly restored cell viability affected by acrolein in Nox1-disrupted clones, but not in mock-transfected cells. Similarly, pretreatment with reversan significantly restored cell viability reduced by 20 lM MVK in Nox1-disrupted clones, but not in mock-transfected cells (Fig. 6B ). When we examined glutathione levels in these cells, treatment with reversan alone did not affect the levels in either wild-type or Nox1-disrupted cells. In wild-type cells, glutathione levels were unchanged by acrolein treatment in the presence or absence of reversan (Fig. 6C ). On the other hand, in Nox1-disrupted cells, treatment with acrolein tended to deplete cellular glutathione, which was significantly restored by the addition of reversan (Fig. 6D) . These findings clearly demonstrate a causal link between upregulation of MRP1 and increased vulnerability to acrolein and MVK in Nox1-disrupted cells.
Discussion
Cigarette smoking has been documented to stimulate NOX-mediated ROS production in the cardiovascular system, leading to the development of cardiovascular diseases [4, 5] . In C6 glioma cells, diphenyleneiodonium, an inhibitor of flavoproteins including NOX, significantly suppressed the cytotoxic effects of major toxic components of cigarette smoke extracts, acrolein and MVK [2] . During the course of this study, increased expression of the NOX1 isoform of NADPH oxidase caused by cigarette smoke extracts was reported in vascular smooth muscle cells [15, 16] . However, the role of NOX1 in smoking-induced cardiotoxicity has not been investigated. We revealed a novel role of NOX1 in protection against acrolein-and MVK-induced cardiomyocyte damage. NOX1 preserved cellular GSH levels by regulating the expression of MRP1, which mediates the cellular efflux of GSH [17] .
Apart from the NOX1 isoform of NADPH oxidase, expression of NOX2 and NOX4 was demonstrated in the murine heart [9] . NOX2 was reported to mediate angiotensin II-induced cardiac hypertrophy, while NOX4 reportedly mediated cardiac hypertrophy and heart failure in response to pressure overload [18] . In our study, NOX2 was marginally expressed in H9c2 cells, and disruption of Nox2 did not affect cell viability in the presence of acrolein or MVK. Disruption of Nox4 augmented acrolein-or MVK-induced cytotoxicity, but Nox1-disrupted cells were more vulnerable to acrolein and MVK at lower concentrations. This is in marked contrast to the abundant expression of NOX4 in H9c2 cells compared with NOX1. Among the isoforms expressed in cardiac tissue, NOX1 has been relatively under-represented due to its low expression. Of interest in this regard, the protective role of NOX1 was previously demonstrated against hypoxia-induced bradycardia. Compared with wild-type mice, hypoxic perfusion rapidly decreased the heart rate in mice deficient in Nox1 [12] .
The impact of cellular GSH levels on the cytotoxic effect of acrolein and MVK has been documented. Acrolein-induced toxicity was attributed to its conjugation with GSH, resulting in the depletion of cellular GSH [13] . Likewise, MVK-induced apoptosis was associated with the depletion of GSH accompanied by disruption of the mitochondrial transmembrane potential [19] . In recent mass spectra analysis, the GSH-MVK adduct was identified as a major product formed in cells exposed to cigarette smoke extracts 
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Mock clone 1 clone 2 clone 3 [14]. Here, a significant decrease in total glutathione as well as GSH levels was demonstrated in Nox1-disrupted H9c2 clones. In fact, a partial decline in glutathione levels significantly exacerbated acrolein-and MVK-induced toxicity in cells cultured with a reduced L-cystine concentration. Our findings therefore support the importance of cellular GSH in susceptibility to cigarette smoke-induced toxicity. Disruption of Nox1 led to the significant upregulation of MRP1 without a notable change in the GSHsynthesis pathway. ROS-linked regulation of the multidrug resistance transporter, P-glycoprotein (P-gp), 
Mock clone 1 clone 2 clone 3 was previously reported in prostate tumor spheroids, while GSH is not a substrate for P-gp. In DU-145, a human prostate cancer cell line overexpressing NOX1, the expression of P-gp was significantly decreased compared with the mother cell line, which was accompanied by the increased retention of an anticancer drug [20] . In this context, our findings were in line with the results obtained in NOX1-overexpressing cells, in that the disruption of Nox1 increased the expression of MRP1, a member of the ATP-binding cassette family of transporters that affects the retention of GSH. Although speculative, ROS derived from NOX1 might consistently maintain the level of intracellular GSH by suppressing the expression of its efflux transporter. The molecular mechanism underlying the NOX1-mediated regulation of MRP1 expression is unclear. Involvement of microRNA (miR) in the degradation of MRP1 mRNA was demonstrated in a HepG2 human hepatocellular carcinoma cell line transfected with miR133a or miR-326 mimics [21] . Similarly, an inverse relationship between miR-7 and MRP1 expression was depicted in a human small cell lung cancer cell line. A higher expression level of miR-7 was found in the drugsensitive group of patients with small cell lung cancer, and it was significantly correlated with a higher overall survival rate [22] . These findings suggest the involvement of miRs in mRNA degradation and the expression of MRP1. On the other hand, the NADPH oxidasedependent regulation of miR was documented in prostate cancer cells. Reduced expression of oncogenic miR-21 was shown in cells transfected with small interfering RNA against NADPH oxidase subunit p47phox [23] . Interestingly, cardioprotective roles of miR-21 have been reported in mouse models of heart failure [24] . These findings support the idea that ROS derived from NOX1 may maintain the level of miR that downregulates MRP1 expression. However, we could not find any predicted target sites of these miRs by computational analyses of the 3 0 -untranslated region of rat MRP1 mRNA. Whether NOX1 affects the biogenesis of miR that downregulates MRP1 in cardiomyocytes is still an open question.
In conclusion, a protective role of NOX1/NADPH oxidase against acrolein-and MVK-induced cellular damage was demonstrated in H9c2 cardiomyocytes. By regulating the expression of MRP1, which modulates cellular GSH levels, NOX1/NADPH oxidase may counteract the detrimental effects of cigarette smoking. Certainly, further investigation is necessary to support the results in man.
Materials and methods
Reagents
Acrolein was purchased from Tokyo Chemical Industry Co., Ltd (Tokyo, Japan) and methyl vinyl ketone (3-buten-2-one: MVK) was purchased from Merck (Darmstadt, Germany).
Cell culture
A rat myoblast H9c2 cell line obtained from the American Type Culture Collection (Rockville, MD, USA) was cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS.
CRISPR-Cas9-mediated genome editing
Nox1-, Nox2-, and Nox4-disrupted clones were previously established [10] . CRISPR design was used to construct single guide RNAs. gRNA_Cloning Vector was a gift from George Church (Addgene plasmid no. 41824) [25] and used as a cloning backbone. pCAG-hCas9, a Cas9 expression vector, was a gift from Izuho Hatada (Addgene plasmid no. 51142) [26] .
Cytotoxicity assay
Cytotoxicity was evaluated by determination of the number of viable cells based on the amount of ATP present in culture, using a CellTiter-Glo luminescent cell viability assay kit (Promega, Madison, WI, USA 
PCR analysis
Expression of mRNAs was evaluated by RT-PCR or qPCR as previously described with minor modifications [8] . Total RNA was isolated by Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, Japan) according to the manufacturer's instructions. RNA was reverse transcribed using PrimeScript RT Reagent Kit (Takara Bio). qPCR was performed using the GeneAmp 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) with the TB Green Premix Ex Taq II (Takara Bio). The primer sequences used were as follows: Nox1, 
Western blot analysis
Protein was extracted by homogenizing cells in lysis buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT, protease inhibitor cocktail in PBS, protease inhibitor cocktail; Merck), and centrifugation at 8000 g for 20 min. The supernatant fraction was subjected to western blot analysis. An aliquot of 30 lg of protein was separated by electrophoresis and transferred onto a PVDF membrane. After blocking for 1 h at room temperature, membranes were incubated overnight at 4°C with primary antibodies. Immunoreactive bands were detected by chemiluminescence following incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies. The band intensity was quantified densitometrically using IMAGEJ software (NIH, Bethesda, MD, USA). The primary antibody used was against xCT (1 : 500, ab175186; Abcam) or GAPDH 
Measurement of glutathione levels
Levels of GSH and GSSG were determined by a GSSG/ GSH Quantification Kit (Fujifilm Wako Pure Chemical Corp., Osaka, Japan) according to the manufacturer's instructions.
Measurement of GCL activity
GCL activity was determined by the reaction of naphthalene dicarboxaldehyde (Tokyo Chemical Industry, Tokyo, Japan) with GSH or c-glutamylcysteine (c-GC) to form cyclized products that are highly fluorescent. Experiments were carried out as previously described [27] .
Statistical analysis
The results are expressed as the mean AE SEM. Statistical analysis was performed using Student's t-test to compare the means of two groups. The Bonferroni test was applied to compare between multiple groups. P-values less than 0.05 were regarded as significant.
